Learn how Carl Ola Landgren is creating a risk profile to personalize myeloma care – HealthTree Foundation

HealthTree Foundation shared on X:

“Learn how Dr. C. Ola Landgren and his colleagues at the University of Miami are building a sophisticated computational model to predict risk and the optimal treatment path for individual multiple myeloma patients.

Thanks to our sponsor, Karyopharm.”

Carl Ola Landgren replied saying:

“Thank you Health Tree Foundation for inviting me to join this exciting podcast! The future is bright for myeloma patients.”

Source: HealthTree Foundation/X and Carl Ola Landgren/X

Carl Ola Landgren is a Professor of Medicine, Chief of the Myeloma Division at the University of Miami, and a Leader of the Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center.

His clinical and scientific focus has been on the development of novel treatment strategies for patients with myeloma, partnered with molecular profiling (personalized oncology), and developing technologies for minimal residual disease (MRD) assessment. He has published over 450 peer-reviewed articles in high-impact journals.